Last reviewed · How we verify
Amoxicillin Long
At a glance
| Generic name | Amoxicillin Long |
|---|---|
| Sponsor | Universita degli Studi di Genova |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effectiveness of the Eradication of Helicobacter Pylori and an Inhibitor of Pump With Proton Versus Control (PHASE4)
- A Platform Trial for Gram Negative Bloodstream Infections (NA)
- Freeze-dried Bone Allograft vs Autologous Bone Blocks in the Lateral Augmentation of the Jaws (NA)
- The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients (PHASE4)
- Amoxicillin Plus Metronidazole in Periodontal Maintenance (NA)
- Short Post-surgical Antibiotic Therapy in Spine Infections - a Prospective, Randomized, Unblinded, Non-inferiority Trial (NA)
- The Application of a Biphasic Calcium Sulfate Graft Material in Sinus Floor Elevation (NA)
- Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Amoxicillin Long CI brief — competitive landscape report
- Amoxicillin Long updates RSS · CI watch RSS
- Universita degli Studi di Genova portfolio CI